Purchase Order 75F40118P20320
Award Date 8/23/18
Potential Completion Date 9/29/21
Potential Value $529K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for perpetual access to the ScienceDirect backfile collections for Cell Press and custom single titles. The contract has a ceiling value of $88,427.00 and a period of performance ending on June 29, 2016. Elsevier B.V. is a global information analytics company that provides scientific, technical, and medical content, including journals, books, and...
- This is a $76,649.53 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a global information analytics company, for annual online access to reference modules, ebooks, and journals in the biomedical sciences. The contract was awarded as a sole-source requirement with no set-aside designation. The contract provides the FDA Library with enterprise-wide access to Elsevier's platforms, such as ScienceDirect, Scopus, Reaxys, and Embase, which contain...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for an enterprise-wide site license to access the ScienceDirect online database and platform. The $3,446,570.86 contract has a completion date of December 31, 2021 and was awarded on December 19, 2018. Elsevier is a global information analytics company that provides scientific, technical, and medical content to...
- This firm-fixed-price purchase order, valued at $105,243.00, was awarded by the Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS) to Elsevier B.V., doing business as North-Holland (Publishing), for annual access to Elsevier's online eBook collections. Elsevier B.V. is a global information analytics company that predominantly provides the U.S. government with access to its various online databases and platforms, such as ScienceDirect, Scopus, Reaxys,...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Elsevier B.V., a global information analytics company doing business as North-Holland (Publishing). The $109,322.00 contract provides the FDA with a web-based subscription to Elsevier's KNOVEL platform, which contains scientific, technical, and medical content, including journals, books, and databases. This contract has no...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier Inc., a leading global provider of scientific, technical, and medical information products and services. The contract, valued at $107,500.00, is for the provision of FAERS SOFTWARE - EMBASE, a proprietary medical research platform, over a 4-year period from May 2024 to April 2028. Elsevier holds two significant federal Indefinite Delivery Vehicles (IDVs) with the Library of Congress and the...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm-fixed-price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for a $153,240 license to access the Pharmapendium database. Pharmapendium is a unique database that integrates preclinical, clinical, and post-market safety data from Food and Drug Administration (FDA) approval packages, providing comprehensive information on...
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a subsidiary of Reed International PLC, to provide a subscription to the EMBASE.COM research database. The contract has a ceiling value of $225,758.00 and a period of performance from January 13, 2014 to January 13, 2019. Elsevier is a global information analytics company that specializes in scientific, technical, and medical content publishing. This contract does not have a...
- This is a firm-fixed-price delivery order contract awarded to Elsevier B.V., doing business as North-Holland (Publishing), by the Office of the Director at the Department of Health and Human Services (HHS) on September 1, 2024. The contract, valued at $218,444.00, provides the U.S. government with access to Elsevier's various online databases and platforms, such as ScienceDirect, Scopus, Reaxys, and Embase, which contain scholarly literature, patents, chemical substance information, and other...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $1.77 million firm fixed price delivery order contract to Elsevier B.V., doing business as North-Holland Publishing, to provide access to Elsevier's Sciencedirect online services including Sciencedirect, Reaxys, Scopus, and Embase through December 2021. As a prime contractor, Elsevier will deliver online access to these scientific databases and literature platforms...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Elsevier B.V., doing business as North-Holland (Publishing), for a PharmacoKinetic and Metabolizing Enzyme Modules subscription. The contract has a potential value of $529,066.01 and a completion date of September 29, 2021. The contract provides the FDA Library with unlimited online access to Elsevier's databases, including drug safety and efficacy data, to support the agency's medical and biomedical research initiatives. This contract was awarded on a sole-source basis and did not utilize any set-aside designations.
Generated 3/23/24, 3:30 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmapendium Drug Resource Tool | FDA-223-18-NOI-1194713 | Department of Health and Human Services Food and Drug Administration | Special Notice 1/1 | 3/23/18, 6:11 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $182.5k | 3/16/20 | |
| P00002 | Exercise an Option | $176.3k | 7/15/19 | |
| P00001 | Other Administrative Action | $0 | 12/20/18 | |
| Not listed | Not listed | $170.3k | 8/23/18 |